Curriculum Vitae of Dr. Bob S. Carter
Attending Neurosurgeon, Massachusetts General Hospital
Harvard Medical School
Updated 4/10/2003
Office Address: VBK 730, Massachusetts General Hospital, Boston, MA 02114
Phone: 617-726-3360, Fax: 617-726-3365 E-mail: bob_carter@harvard.edu
PART I: EDUCATION AND TRAINING ...............................................................................................................3
PLACE OF BIRTH: .......................................................................................................................................................3
EDUCATION: ..............................................................................................................................................................3
POSTDOCTORAL TRAINING: .......................................................................................................................................3
Internship and Residency: ....................................................................................................................................3
Research Fellowships: .........................................................................................................................................3
LICENSURE AND CERTIFICATION: ..............................................................................................................................3
ACADEMIC APPOINTMENTS: ......................................................................................................................................3
HOSPITAL APPOINTMENTS: ........................................................................................................................................3
MAJOR COMMITTEE ASSIGNMENTS: ..........................................................................................................................4
National and Regional: ........................................................................................................................................4
Hospital: ..............................................................................................................................................................4
PROFESSIONAL SOCIETIES: ........................................................................................................................................4
EDITORIAL ACTIVITIES: .............................................................................................................................................4
AWARDS AND HONORS: .............................................................................................................................................4
PART II: RESEARCH, TEACHING, AND CLINICAL CONTRIBUTIONS .....................................................5
A.
B.
C.
D.
NARRATIVE REPORT OF RESEARCH, TEACHING, AND CLINICAL CONTRIBUTIONS: .............................................5
RESEARCH FUNDING INFORMATION .....................................................................................................................5
REPORT OF CURRENT RESEARCH ACTIVITIES: .....................................................................................................6
SELF REPORT OF TEACHING ...............................................................................................................................6
Local Contributions: ............................................................................................................................................6
Harvard Medical School Courses:..................................................................................................................................... 6
Local Invited Presentations: .............................................................................................................................................. 7
Continuing Medical Education ............................................................................................................................7
Departmental Teaching Role ...............................................................................................................................8
Regional, National, and International Contributions: .........................................................................................8
Advisees/Trainees: ...............................................................................................................................................9
E. REPORT OF CLINICAL ACTIVITIES.......................................................................................................................9
PART III. BIBLIOGRAPHY ....................................................................................................................................9
ORIGINAL ARTICLES ..................................................................................................................................................9
REVIEWS, CHAPTERS, AND EDITORIALS: ................................................................................................................. 12
DOCTORAL THESIS: ................................................................................................................................................. 13
ABSTRACTS: ............................................................................................................................................................ 13
Page 2
Part I: Education and Training
Place of Birth:
Education:
o
o
o
o
o
1992 M.D. Johns Hopkins University, Baltimore, MD
1992 Ph.D. Genetic Epidemiology, Johns Hopkins University, Baltimore, MD
1990 Certificate, Short Course in Medical and Experimental Mammalian Genetics, The Jackson
Laboratory, Bar Harbor, Maine
1986 B.A, Brigham Young University, Provo, UT
1982 Certificate in French, Laval University, Quebec City, Canada
Postdoctoral Training:
Internship and Residency:
o
o
1993-1998 Resident in Neurosurgery, Massachusetts General Hospital
1992-93 Surgical Intern, Massachusetts General Hospital, Boston, MA
Research Fellowships:
o
o
1996-1997 Post-doctoral Fellow in Richard Mulligan Laboratory, Whitehead Institute and Dept. of
Genetics, Children’s Hospital Harvard Medical School, Cambridge MA
1987 NIH-Summer Research Fellow, Laboratory of Keiko Ozato, Ph.D. NIH, Laboratory of
Molecular Immunity, Bethesda, MD
Licensure and Certification:
o
o
1996 American Board of Neurological Surgeons Written Examination
1993 Massachusetts License, #81316
Academic Appointments:
o
o
o
1992-1998 Clinical Fellow in Surgery, Harvard Medical School
1998 (12/98) - Instructor in Neurosurgery, Harvard Medical School
2001 (4/01)-Assistant Professor of Surgery (Neurosurgery) Harvard Medical School
Hospital Appointments:
o
o
o
1996-1997 Graduate Assistant in Emergency Medicine, Massachusetts General Hospital
1998 Graduate Assistant in Neurosurgery, Massachusetts General Hospital
1998 (12/98)- Staff Neurosurgeon, Massachusetts General Hospital
Page 3
Major Committee Assignments:
National and Regional:
o
o
o
o
o
1998 Outcomes Committee AANS/CNS
1999 Boston Operation Stroke, Medical SubCommittee
2000-2001 American Heart Association, Boston Awards Luncheon Committee
2002-National YN Neurosurgeons Committee, American Association of Neurologic Surgeons.
Elected in to 4 year term in national election.
2003-American Association of Neurologic Surgeons Internet Education Committee
Hospital:
o
o
o
o
1999-2003 Director, MGH Neurosurgery Grand Rounds, Neurosurgical Service, Massachusetts
General Hospital
1999 Provider Order Entry Implementation Committee, Massachusetts General Hospital
1999 Emergency Ward Census Committee, Massachusetts General Hospital
1998 Administrative Chief Resident, Neurosurgical Service, Massachusetts General Hospital
Professional Societies:
o
o
o
o
o
o
o
2002 American Society for Gene Therapy
1999 Joint Section on Tumors AANS/CNS
1998 Joint Section on Cerebrovascular Surgery AANS/CNS
1993 American Association of Neurologic Surgeons, Member
1993 Congress of Neurological Surgeons, Member
1990 American Association for Cancer Research, Associate Member
1990 Society for Epidemiologic Research
Editorial Activities:
Ad Hoc Reviewer for
o
o
o
o
Neurosurgery 1994Human Gene Therapy 1999Stroke 2000Journal of Gene Medicine-2001
Awards and Honors:
o
o
o
o
o
o
2000 Partners in Excellence Award, Massachusetts General Hospital. Partners Healthcare
1998 Preuss Resident Cancer Research Award, Joint Section on Neuroncology, AANS/CNS
1995 Upjohn Fellowship in Cerebrovascular Disease. AANS/CNS Jt. Section of Cerebrovascular
Surgery
1992 Alpha Omega Alpha, Johns Hopkins School of Medicine
1992 Phi Beta Kappa, Johns Hopkins School of Medicine
1992 Phi Beta Kappa, Johns Hopkins School of Public Health
Page 4
o
o
o
o
o
o
o
o
o
o
o
o
o
o
1992 Upjohn Travel Award, Am. Assoc. for Cancer Research
1992 Academy of Academic Surgeons Student Research Award-First Prize
1992 Ehrlich Award for Clinical Investigation, Johns Hopkins School of Medicine
1992 Delta Omega (National Public Health Honor Society)
1991 JHU Department of Epidemiology, Doctoral Research Grant
1990 First Prize, Society for Basic Urologic Research Essay Contest
1988 PreDoctoral Cancer Training Fellowship, National Cancer Institute
1987 Summer Research Fellowship, National Institutes of Health, Bethesda, MD
1986 Graduated with University Honors (One of eight of 4873 graduates), BYU
1986 Student Commencement Speaker, Brigham Young University
1985 Pi Delta Phi French Honorary Society
1985 Phi Kappa Phi (Inducted as Junior)
1981-82 Barret Scholar, Brigham Young University, (Full tuition)
1984-86 Hinckley Scholar, Brigham Young University, (Full tuition)
Part II: Research, Teaching, and Clinical Contributions
A. Narrative Report of Research, Teaching, and Clinical
Contributions:
I have an active research interest in the development and delivery of gene therapy vectors for
CNS disorders including cellular engineering using chimeric T-cell receptors for glioma therapy,
gene transfer of anti and pro-angiogenic molecules for cancer and ischemia applications, and
development of novel methods for CNS gene transfer. These activities are supported by a 5 year
NIH Career Research Award, the Bayer Research Foundation, the Brain Tumor Society and the
Goldhirsh Foundation. In this role, I have an active effort in mentoring post doctoral fellows as
well as supervising the activity of research technicians. Teaching efforts include organization of
MGH Department of Neurosurgery continuing education grand rounds. As part of our Harvard
Medical School curriculum for rotating students in neurosurgery, I conduct teaching sessions
with each student rotating on the service discussing cerebral trauma including pathophysiology
and clinical management. On the national level, I am an active member of the Joint Sections on
Cerebrovascular Surgery and Neuro-oncology and have regular teaching assignments in
seminars at the national meetings of these organizations.
B. Research Funding Information
o
o
o
o
2002-2005. Goldhirsh Foundation “Human Anti-EGFRvIII CTL’s”
2003-2004. Dana Farber/Harvard Cancer Center . “Convection Enhanced Delivery of AdenoAssociated Viral vectors endoding Anti-Angiogenic Proteins” $75K/year direct costs with coinvestigator, Dr. Cheryl Baker at Children’s Hospital.
2001. Genethon. "Cooperative Investigation of SNV vector transduction in the central nervous
system"
2001-2003. The Brain Tumor Society. "Genetically Engineered Anti-EGFRvIII CTL's for Glioma"
$50K per year direct costs
Page 5
o
o
o
o
o
o
2000-2005. NIH Career Research Award. National Cancer Institute "Genetically Engineered
Anti-Angiogenic Anti-Glioma CTL's"
2000. Bayer Research Fellowship "An Investigation Into Gene and Stem Cell Based Therapies for
Stroke"
1997-1998 CaP Cure Foundation: Genetically Engineered Anti-Tumor Anti-Angiogenic
Cytotoxic Lymphocyte Therapy for Prostate Cancer. Co-investigator: Richard Mulligan, Ph.D.
1996 The Brain Tumor Society: Genetically Engineered Anti-Angiogenic Anti-Tumor Cytotoxic
Lymphocytes: A Novel Immunotherapeutic Strategy for Malignant Glioma. Co-investigators:
Richard Mulligan, Ph.D., Zoher Ghogawala M.D.
1996 National Cancer Institute Post-Doctoral Fellowship: Stem Cell Based Anti-angiogenic AntiTumor Therapy
1995 UpJohn Co. AANS Joint Section on Cerebrovascular Surgery: Retroviral Targeting of the
Cerebrovascular Endothelium via the VEGF/Flk-1 receptor ligand interaction.
C. Report of Current Research Activities:
o
o
o
o
o
D.
Bench Project: "Genetically Engineered Anti-Angiogenic Anti-Glioma CTL's"- Role: Primary
investigator on NIH career research award. Primary Investigator on Goldhirsh Foundation Grant
and Brain Tumor Society Grant. The goal of this project is to genetically engineer CD8+
lymphocytes to attack the EGFRvIII mutation present on human glioblastoma as well as VEGF
receptors on the developing vasculature of these tumors. Currently supervise the activity of one
post-doctoral fellow and two research technicians.
Bench Project: “Adenoviral delivery of Anti-angiogenic Agents” Role:Primary Investigator.
We are examining the effects of in vivo delivery of anti-angiogenic adenoviruses in the U87
glioma model.
Bench Project: "An Investigation into Gene and Stem Cell Based Therapies for Stroke" Role:
Primary investigator. This project involves the development on viral vectors as stroke treatments
as well as the development of stem cell based therapies for cellular replacement after stroke.
Includes collaborative efforts with scientists from the Genethon organization to develop novel
vectors for CNS transduction.
Bench Project: “Convection Enhanced delivery of Viral Vectors in the Central Nervous System”
Currently co-developing project with Drs. Richard Mulligan and Krys Bankiewicz for new
delivery techniques for viral vectors in the central nervous system.
Clinical Project: "Outcome Studies in Cerebrovascular Disease" Role: Investigator in a series of
studies examining standard outcome measures after subarachnoid hemorrhage, intracerebral
hemorrhage, large volume ischemic stroke, and unruptured aneurysm treatments.
Self Report of Teaching
Local Contributions:
Harvard Medical School Courses:

Faculty Member: Harvard Medical School Elective "Clinical Neurosurgery", Average 1-3
students per month with 1-2 individual student sessions per month.
Page 6
Local Invited Presentations:

















December 2002. New England Journal of Medicine Clinicopathological Case Conference
Presentation “Hemicraniectomy for Stroke”
August 2002. MGH Neurology Summer Course. “Cerebral Trauma”
February 2002. Massachusetts General Hospital. Neurosurgery Grand Rounds. "Unruptured
Intracranial Aneurysms"
November 2001, Neurology Grand Rounds. Hemicraniectomy for Malignant Brain Edema
September 2001. Neurology Residents Course "Neurosurgical Emergencies"
December 2000. Massachusetts General Hospital. Department of Medicine Grand Rounds.
"Diagnosis and Treatment of Cervical Atheromatous Disease"
June 2000. Massachusetts General Hospital. Department of Neurosurgery Grand Rounds.
"Outcome after Aneurysm Management in the Elderly"
May 2000. Massachusetts General Hospital. Department of Neurosurgery Grand Rounds.
"Intracranial and Carotid Stenting"
March 2000. Massachusetts General Hospital. Department of Neurosurgery Grand Rounds.
"Hemicraniectomy: Indications and Outcomes"
February 2000. Massachusetts General Hospital. Department of Neurosurgery Grand Rounds.
"Outcome after Subarachnoid Hemorrhage"
September 1999 Massachusetts General Hospital. Department of Neurosurgery Grand Rounds.
Amyloid Associated Lumbar Arthropathy
June 1999 Massachusetts General Hospital. Department of Neurosurgery Grand Rounds. North
Neurosurgical Service Report
July 1998. Massachusetts General Hospital. Department of Neurosurgery Grand Rounds.
Genetic Strategies Against Angiogenesis
June 1998. Combined Neurosurgical Service Research Retreat Harvard Medical School. Novel
Glioma Therapies: Designer T-cells and Anti-angiogenic Gene Therapy.
June 1998. Massachusetts General Hospital. Department of Neurosurgery Grand Rounds. "The
Role of Radiation Therapy in the Treatment of Benign Meningioma"
April 1998. Massachusetts General Hospital. Department of Neurosurgery Grand Rounds. "The
Cavernous Sinus"
1990, Lecture: "The Familial Aggregation of Prostate Cancer", Oncology Grand Rounds, The
Johns Hopkins Oncology Center.
Continuing Medical Education





May 30 2003 Harvard Medical School Continuing Education Course: “Neurovascular Update”
Lecturer “Surgery for Stroke” (scheduled)
May 30 2003 Harvard Medical School Continuing Education Course: “Neurovascular Update”
Lecturer “Surgery for Intracerebral Hemorrhage” (scheduled)
May 2002 Harvard Medical School Continuing Education Course: “Neurovascular Update”
Lecturer “Hemicraniectomy for Stroke”
May 2001 Harvard Medical School Continuing Education Course. "Neurovascular Update:
Cavernous Malformations"
May 2001 Harvard Medical School Continuing Education Course: "Neurovascular Update:
Surgery for Intracranial Aneurysms"
Page 7








September 1999. Harvard Medical School Continuing Education Course. "Brain Attack: Minutes
Count" Surgical Therapy for Acute Stroke
May 1999 Harvard Medical School Continuing Education Course. Neurovascular Update 1999
and Beyond. "Acute Surgery for Stroke"
March 1998. Invited Lecturer. "Cerebral Perfusion Pressure Management" Harvard Medical
School Continuing Education Course. "Minutes Count: Intracranial Hemorrhage and Stroke
Diagnosis, Treatment and Recovery
Sept 1995, Invited Lecturer, "Long term outcome after SAH" Harvard Medical School Continuing
Education Course: "Stroke and Subarachnoid Hemorrhage"
Sept 1995, Lecturer, "Decompressive Surgery for Stroke" Harvard Medical School Continuing
Education Course: "Stroke and Subarachnoid Hemorrhage"
October 1996, Invited Lecturer, "Emergent Surgical Therapy for Stroke" Harvard Medical School
Continuing Education Course, "Minutes Count: Emergency Management of Cerebrovascular
Ischemia"
April 1992, Invited lecturer, "Familial Studies of Prostate Cancer", 19th Annual Johns Hopkins
Oncology Center Postgraduate course on neoplastic disease.
1990-1991, Lecturer, Cancer Epidemiology Course, Johns Hopkins Univesity School of Hygiene
and Public Health
Departmental Teaching Role

Director, Department of Neurosurgery Grand Rounds-1999-present. Involves development of
year grand rounds program and all administrate aspects of the course. See course website:
http://www.neurosurg.info
Regional, National, and International Contributions:










April 2003. Invited Faculty. “Neurocritical Care” American Association of Neurologic Surgeons
Meeting. Critical Care course. San Diego, CA.
April 2002. Invited Faculty. "Neurocritical care" American Association of Neurologic Surgeons
Meeting. Critical Care course. Chicago, IL.
April 2002. Invited Faculty. Connecticut Neurological Society Annual Meeting
"Hemicraniectomy for Stroke" Hartford, CT
February 2002. Invited Faculty. "Neurovascular Critical Care" Joint Section on Cerebrovascular
Surgery. Dallas, TX
September 2001. Invited Faculty. "Carotid Disease" Congress of Neurologic Surgeons
September 2001. Invited Faculty. "Neurosurgical Critical Care" Congress of Neurologic
Surgeons
June 2001. Presentation on "Stem Cell Based Therapy for Stroke" to Bayer Fellowship Committee,
Amelia Island Plantation Florida
April 2001. Instructor. American Association of Neurologic Surgeons. Critical Care Management
Course, Toronto, CA
February 2001. Instructor Joint Section on Cerebrovascular Surgery. Critical Care Management
Course. Kona, HI.
September 2001. Moderator. Scientific Open Program. Congress of Neurologic Surgeons
Meeting. San Antonio, TX
Page 8





June 2000. Invited Lecturer. 6th International Cerebrovascular Workshop. Seoul, Korea.
"Outcome after Subarachnoid Hemorrhage" and "Managment of Fusiform Aneurysms"
February 2000. Invited Lecturer. Joint Section of Cerebrovascular Disease, New Orleans, LA.
"Cavernous Malformations"
Sept 1998. Preuss Award Presentation. A Novel Secreted form of the Angiogenesis Inhibitor
Endostatin Inhibits the Growth of Human Glioma Xenografts. Joint Section of Neuroncology,
Congress of Neurologic Surgeons, Seattle WA 1998
February 1997. Invited Lecturer. "Genetic Strategies Against Glioma" Johns Hopkins Oncology
Center
March 1996. Invited Lecturer. The Role of Growth Factors in Brain Angiogenesis. Society of
Neurochemistry Annual Meeting, Philadelphia, PA
Advisees/Trainees:








E.
Manish Sethi, M.D. Candidate 2002 Summer student
Ilya Liviz, D.M.D. Candidate 2002, Summer research student
Oscar Szentirmai, M.D., Post-Doctoral Fellow, Current Trainee 1999Szofia Szucs, M.D., Post-Doctoral Fellow 2002-present
Yorell Manon-Matos-Dartmouth Medical Student 2001
Sarah Bradford, Undergraduate Student, Dartmouth College. 2000.
Martin Ollenu, M.D., Current Rotation Student, Karolinska Institute, Sweden 2000.
Jenny Wang, MIT Undergraduate UROP program. M.D. Candidate Northwestern University
1997.
Report of Clinical Activities
Dr. Carter's clinical neurosurgical practice is based at Massachusetts General Hospital in
cerebrovascular and skull base tumor surgery. Dr. Carter performs over 200 intracranial
procedures per year. Clinical research efforts include an active effort to define the indications
and use of hemicraniectomy for acute brain swelling in the setting of malignant hemispheric
cerebral infarction.
Part III. Bibliography
Original Articles
1.
2.
3.
Carter BS, Carter HB, Isaacs JT. Epidemiologic Evidence Regarding Predisposing Factors to
Prostate Cancer (1990) Prostate 16:187-197.
Carter BS, Epstein JI, and Isaacs WB ras Gene Mutations in Human Prostate Cancer. (1990)
Cancer Res. 50:6830-6832
Steinberg GD, Carter BS, Beaty TH, Childs B, and Walsh PC. Family History and the Risk of
Prostate Cancer. (1990) Prostate 17:337-347.
Page 9
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
Carter BS, Ewing CM, Ward WS, Treiger BT, Aalders TW, Schalken JA, Epstein, JI, and Isaacs WB
Allelic Loss On Chromosomes 10q and 16q in Human Prostate Cancer. (1990) Proc. Natl. Acad.
Sci. 87:8751-8755.
Quinlan DM, Epstein JI, Carter BS, and Walsh PC. Sexual Function following Radical
Prostatectomy: Influence of Preservation of Neurovascular Bundles (1991) Journal of Urology
145:998-1002.
Isaacs WB, Carter BS, and Ewing CM. Wild type p53 Suppresses Growth of Human Prostate
Cancer Cells containing Mutant p53 Alleles. (1991) Cancer Research, 51:4716-20.
Newmark JR, Hardy DO, Tonb DC, Carter BS, Epstein JI, Isaacs WB, Brown TR, and Barrack ER.
Androgen receptor mutation in human prostate cancer. (1992) Proc Natl Acad Sci (USA)
89:6319-23.
Carter BS, Beaty TH, Steinberg GD, Childs B and Walsh PC. Mendelian Inheritance of Early
Onset Familial Prostate Cancer. (1992) Proc Natl Acad Sci (USA) 89: 3367-3371.
Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debryne FM, and
Isaacs WB. Decreased expression of e-cadherin in high grade prostatic carcinomas. (1992) Cancer
Research 52:5104-9.
Carter BS, Bova GS, Steinberg GD, Beaty TH, Isaacs WB, and Walsh PC. Hereditary Prostate
Cancer: Clinical and Epidemiologic Features (1993) Journal of Urology 150:797-802.
Bova GS, Carter BS, Bussemakers MJG, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson
JC, Epstein JI, Walsh PC, and Isaacs WB. (1993) Homozygous deletion and frequent allelic loss of
chromosome 8p22 loci in human prostate cancer. Cancer Research 53:3869-3873.
Brooks JD, Bova GS, Ewing CM, Piantadosi S, Carter BS, Robinson JC, Epstein JI, Isaacs WB. An
uncertain role for p53 gene alterations in human prostate cancers. Cancer Research 56:3814-3822.
(1996)
Ogilvy CS, Carter BS, Kaplan S, Rich C, Crowell RM. Factors affecting stroke incidence during
aneurysm surgery with temporary vessel occlusion in patients protected by hypertension,
hypothermia, and intravenous mannitol. J Neurosurg 84, 785-791 (1996)
Carter BS, Ogilvy CS, Rosas, H.D., Buonanno F. Long term Outcome after Hemicraniectomy for
Massive Non-dominant Hemispheric Infarction. Neurosurgery 40: 1168-1175, (1997)
Bova GS, Partin SD, Isaacs S, Carter BS, Beaty TL, Isaacs WB and Walsh PC, Biological
Aggressiveness of Hereditary Prostate Cancer: Long Term Evaluation Following Radical
Prostatectomy J. Urology 160: 660-665 (1998)
Ogilvy CS and Carter BS. A proposed comprehensive grading system to predict outcome for
surgical management of intracranial aneurysms. Neurosurgery. 42: 959-968 (1998).
Petterson A, Nagy JA, Brown L, Sundberg C, Morgan E, Jungles S, Carter BS, Krieger JE,
Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak A, Mulligan RC, and Dvorak H.
Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by
Vascular Permeability Factor/Vascular Endothelial Growth Factor. Laboratory Investigation 80:
99-115 (2000)
Carter BS, Buckley D, Ferraro R, Rordorf G, and Ogilvy CS. Factors Associated with
Reintegration to Normal Living after Subarachnoid Hemorrhage. Neurosurgery 46:1326-1334
(2000)
Chung RC, Carter BS, Ogilvy C. Management outcomes for ruptured and unruptured
aneurysms in the elderly. Neurosurgery. 47:827-832 (2000)
Carter BS, Ogilvy CS, Putnam C and Ojemann R. The Case for Selective Use of ExtracranialIntracranial Bypass as an Adjunct to Therapeutic Carotid Artery Occlusion. Clinical
Neurosurgery 46:351-362 (2000)
Page 10
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
Snitkovsky S, Neiderman TM, Carter BS, Mulligan RC, Young JA. A TVA-single-chain antibody
fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells
expressing a tumor-specific form of epidermal growth factor receptor. J. Virol. 74:9540-9545
(2000).
Carter BS, Brisman JA, and Ogilvy CS. Spontaneous Thrombosis of Cerebral Arteriovenous
Malformation in Association with Trauma. Case Report. J. Neurosurg 94:139 (2001)
Hoh BL, Carter BS, Budzik RF, Putman CM, Ogilvy CS. Results after Surgical and Endovascular
Treatment of Paraclinoid Aneurysms by a Combined Neurovascular Team. Neurosurgery 48:7890. (2001)
Hoh BL, Putman CF, Budzik R, Carter BS, Ogilvy CS. Combined surgical and endovascular
techniques of flow alteration to treat fusiform and complex wide-necked intracranial aneurysms
that are unsuitable for clipping or coil embolization. J. Neurosurgery 95:24-35. (2001)
Kuo CJ, Farnebo F, Yu EY, Christofferson R, Swearingen RA, Carter BS, von Recum HA, Yuan J,
Kamihara J, Flynn E, D'Amato R, Folkman J and Mulligan RC. Comparative evaluation of the
antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl. Acad.
Sci.98:4605, 2001.
Niederman TM*, Ghogawala Z*, Carter BS*, Mulligan RC. Genetically Engineered Cytotoxic Tlympocytes with a Killing Specificity for Tumor Vasculature Proceedings of National Academy of
Sciences. 2002 14:7009-7014 *Authors contibuted equally.
Hoh BL, Carter BS, Ogilvy CS. Risk of hemorrhage from unsecured, unruptured aneurysms
during and after hypertensive hypervolemic therapy. Neurosurgery. 50:1207-1211.
Smith ER, Carter BS, Ogilvy CS. Proposed use of prophylactic decompressive craniectomy in
poor-grade aneurismal subarachnoid hemorrhage patients presenting with associated large
sylvian hematomas. Neurosurgery. 51:117-24.
Hoh BL, Chapman PH, Loeffler JS, Carter BS, and Ogilvy CS. Results of multimodality treatment
for 141 patients with brain arteriovenous malformations and seizures: factors associated with
seizure incidence and seizure outcomes. Neurosurgery 51:303-311. 2002
Ogilvy CS and Carter BS. Stratification of outcome for surgically treated unruptured intracranial
aneurysms. Neurosurgery. 2003 Jan;52(1):82-8.
Hoh BL, Rabinov J, Pryor J, Carter BS, Barker F. In-hospital mortality and morbidity after
endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the
effect of hospital and physician volume. In Press, American Journal of Neuroradiology.
Barker FG, Butler W, Amin-Hanjani S, Ogilvy CS, Carter BS. In-hospital mortality and morbidity
after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the
effect of hospital and surgeon volume. Neurosurgery. 2003 May;52(5):995-1007; discussion 10079.
Magavi S, Szentirmai O, Carter BS, Macklis J. “Fate of Adult Born Olfactory Bulb Neurons”
Submitted.
Hoh BL, Carter BS, Putman CM, Ogilvy CS. Important factors for a combined neurovascular
team to consider in selecting a treatment modality for patients with previously clipped residual
and recurrent intracranial aneurysms. Neurosurgery. 2003 Apr;52(4):732-9.
Hoh BL, Curry WT, Carter BS, Ogilvy CS “Occurrence of CT demonstrated cerebral infarcts after
subarachnoid hemorrhage” Submitted.
Kalkanis SN, Eskander E, Carter BS, Barker FG “Microvascular Decompression Surgery in the
United States, 1996 to 2000: Mortality Rates, Morbidity Rates, and the Effects of Hospital and
Surgeon Volumes. Neurosurgery. 2003 Jun;52(6):1251-1262.
Kalkanis SN, Carter BS, Barker FG, “In Hospital Mortality after Acoustic Neuroma Surgery” In
Press, Laryngoscope
Page 11
Reviews, Chapters, and Editorials:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
Carter BS. Surgery for Intracerebral Hemorrhage. Schmidek and Sweet. Operative
Neurosurgical Techniques: Indications and Methods (2003) Invited manuscript in preparation
Carter BS. Hemicraniectomy for cerebral infarction. Schmidek and Sweet. Operative
Neurosurgical Techniques: Indications and Methods (2003) Invited manuscript in preparation
McDonald C, and Carter BS. Medical management of increased intracranial pressure after
spontaneous intracerebral hemorrhage.
Neurosurg Clin N Am. 2002 Jul;13(3):335-8.
Szentirmai O and Carter BS. Genetic and Cellular Therapy for Stroke. Neurosurgery 3rd Ed. In
press (2002)
McDonald C, Carter BS, Putman CM, and Ogilvy CS. "Subarachnoid hemorrhage". Current
Treatment Options in Cardiovascular Medicine 3:429, 2001
Editorial Comment: Carter BS and Ogilvy CS. On "Clinical Manifestations and Survival Rates
among Patients with Saccular Intracranial Aneurysms" Neurosurgery 49: 256. 2001
Barker F and Carter BS. Randomized Clinical Trials in Neursourgery. Neurosurgery Outcomes.
Ed. Harbaugh R. 2002. In press.
Carter BS and Ogivly CS. Outcomes Studies in Cerebrovascular Surgery. Neurosurgery
Outcomes. Ed. Harbaugh, R. 2001 In Press.
Carter BS and Ogilvy CS. Surgical Managment of Vertebral and PICA Aneurysms. Cerebral
Aneurysms, Ed. LeRoux and Winn 2001 In Press
Carter BS and Ogilvy CS. Surgical Management of Intramedullary Cavernous Malformations.
Textbook of Neurologic Surgery, Ed. Batjer and Loftus. 2002.
Carter BS and Ogilvy CS. Editorial Comment on “Early Carotid Endarterectomy after Ischemi
Stroke Improves Diffusion/Perfusion Mismatch on Magnetic Resonance Imaging: Report of Two
Cases” Neurosurgery 52: 238, 2003
Carter BS and Ogilvy CS. Editorial Comment on “Mycotic Aneurysm of the Carotid Bifurcation
in the Neck: Case Report” Neurosurgery 48: 1152, 2001
Carter BS and Ogilvy CS. Editorial Comment on “Radiosurgical Treatment of a Cerebral
Arteriovenous Malformation in a Patient with Moyamoya Disease: Neurosurgery 51:478.
Carter BS and Ogilvy CS. Editorial Comment on “Expression of Vascular Endothelial Growth
Factors in and around Arteriovenous Malformations” Neurosurgery 50: 117
Carter BS and Ogilvy CS. Editorial Comment on “Clinical Manifestations and Survival Rates
among Patients with Saccular Intracranial Aneurysms: Population Based Study in Olmstead
County, MN 1965-1995. Neurosurgery 49:251
Carter BS and Ogilvy CS. Surgical Management of Middle Cerebral Artery Aneurysms.
Contemporary Neurosurgery: 20: 1-9, 1998
Carter BS, Zervas NT, Chiocca EA. Neurogenetic Surgery: Current Limitations and Future
Promise of Gene and Cell Based Therapies. Clinical Neurosurgery 45:226-246, 1999.
Yu JS, Carter BS, Harsh G, Gene Therapy for Cerebral Metastasis, in Advanced Techniques in
Central Nervous System Metastases, Ed: Robert J. Maciunas, MD. AANS Publications 1998
Carter BS, Buckley Dierdre, Ferraro R, and Ogilvy CS Neuroviews: Social, Legal, and Ethical
Implications of Subarachnoid Hemorrhage. UpJohn Co. 1997
Carter BS, Ogilvy CS. Editorial Comment on "Expression of Angiogenic Factors and Structural
Proteins in Central Nervous System Vascular Malformations. Neurosurgery 38:915. 1996.
Page 12
21.
22.
23.
24.
25.
26.
Carter BS and Harsh G. Diagnosis of Suspected Intracranial Metastases: Role of Direct Tissue
Examination. In: Cerebral Metastases. (Harsh G, Ed.), Neurosurgery Clinics of North America
7:425-433. 1996
Carter BS and Ogilvy CS. Emergency management of Stroke with Hemicraniectomy.
Cerebrovascular News. Mass General Hospital. 1995.
Carter BS, Steinberg GD, Beaty TH, Childs B, Walsh PC. Familial Risk Factors for Prostate
Cancer. In: Cancer Surveys on Prostate Cancer - Cellular and Molecular Mechanisms in
Diagnosis and Treatment (Franks, L.M. Ed.), 1992.
Isaacs WB and Carter BS Genetic Changes Associated with Prostate Cancer in Humans. In:
Cancer Surveys on Prostate Cancer - Cellular and Molecular Mechanisms in Diagnosis and
Treatment (Franks, L.M. Ed.), 1992.
Carter BS, Isaacs JT. Predisposing Factors to Prostate Cancer. Reviews on Endocrine Related
Cancer (1990) 34:13-18.
Isaacs WB, Morton RA, Carter BS, Ewing CM, Chevrier M, and Epstein JI. Genomic Alterations in
Prostatic Cancer. In: Molecular and Cellular Biology of Prostate Cancer. (Coffey, D.S., Smith,
R.G., Tindall, D.J., and Karr, J.P., Eds.), Plenum Press, New York, 1992.
Doctoral Thesis:
The Genetic Epidemiology and Molecular Genetics of Human Prostate Cancer. Johns Hopkins
University 1992.
Abstracts:
1.
Over 50 national meeting abstracts in past 10 years with 2-4 oral presentations per year.
Page 13